Moreover, the effect of treatment of gastric cancer cells with HDAC inhibitor TSA was similar to that of 5-aza-dC with regard to differential HDAC1 and HDAC2 binding (Supplementary Figure S2B and S2C). This evidence concerns the gene HDAC2 and gastric cancer.